VIR Vir Biotechnology, Inc.

NASDAQ
$10.77

Vir Biotechnology, Inc. (VIR) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with VIR's own trailing one-year pace, with 100% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 0 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
8
52 transactions
Purchases
$0
0 shares
Sales
$21.0M
3,337,061 shares
Net activity
-$21.0M
purchases less sales

How much of that selling was preplanned? 100% planned / 0% discretionary

10b5-1 plan sales $21.0M 50 transactions · 3,328,897 shares
Discretionary sales $45.8K 2 transactions · 8,164 shares

Largest single sale: $2.8M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Napolitano Janet Director Sell 10b5-1 3,200 $9.45 $30.2K 21,216 −13.1% of holding
Sabatini Brent SVP, Chief Accounting Officer Sell 10b5-1 379 $9.45 $3.6K 61,902 −0.6% of holding
SATO VICKI L Director Sell 10b5-1 22,000 $10.05 $221.0K 1,078,391 −2% of holding
De Backer Marianne President and CEO Sell 10b5-1 72,559 $9.16 $664.4K 948,145 −7.1% of holding
SATO VICKI L Director Sell 10b5-1 22,000 $9.07 $199.6K 1,100,391 −2% of holding
Sabatini Brent SVP, Chief Accounting Officer Sell 10b5-1 7,711 $9.12 $70.3K 61,902 −11.1% of holding
SATO VICKI L 2 fills Director Sell 10b5-1 22,000 $9.51 $209.2K 1,122,591 −1.9% of holding
de Verneuil Vanina EVP, General Counsel, Corp Sec Sell 10b5-1 13,700 $9.82 $134.5K 112,982 −10.8% of holding
Eisner Mark EVP and Chief Medical Officer Sell 10b5-1 1,889 $9.82 $18.5K 154,024 −1.2% of holding
SATO VICKI L 2 fills Director Sell 10b5-1 42,377 $9.75 $413.4K 1,144,591 −3.6% of holding
De Backer Marianne Chief Executive Officer Sell 10b5-1 14,762 $9.53 $140.7K 1,020,704 −1.4% of holding
de Verneuil Vanina EVP, General Counsel, Corp Sec Sell 10b5-1 3,117 $9.53 $29.7K 126,682 −2.4% of holding
O'Byrne Jason EVP & Chief Financial Officer Sell 10b5-1 1,634 $9.53 $15.6K 162,615 −1% of holding
Eisner Mark EVP and Chief Medical Officer Sell 10b5-1 1,616 $9.53 $15.4K 155,913 −1% of holding
Sabatini Brent SVP, Chief Accounting Officer Sell 10b5-1 1,430 $9.53 $13.6K 69,613 −2% of holding
De Backer Marianne Chief Executive Officer Sell 10b5-1 19,039 $7.45 $141.9K 1,035,466 −1.8% of holding
de Verneuil Vanina EVP, General Counsel, Corp Sec Sell 10b5-1 4,445 $7.45 $33.1K 129,799 −3.3% of holding
Eisner Mark EVP and Chief Medical Officer Sell 10b5-1 2,089 $7.45 $15.6K 157,529 −1.3% of holding
O'Byrne Jason EVP & Chief Financial Officer Sell 10b5-1 2,089 $7.45 $15.6K 164,249 −1.3% of holding
Sabatini Brent SVP, Chief Accounting Officer Sell 10b5-1 1,829 $7.45 $13.6K 71,043 −2.5% of holding
Sabatini Brent SVP, Chief Accounting Officer Sell 10b5-1 1,530 $7.79 $11.9K 47,872 −3.1% of holding
SATO VICKI L Director Sell 10b5-1 22,000 $7.71 $169.7K 1,144,391 −1.9% of holding
SATO VICKI L Director Sell 10b5-1 22,000 $5.93 $130.4K 1,166,391 −1.9% of holding
Sell 10b5-1 191,854 $5.98 $1.1M 13,728,924 −1.4% of holding
SATO VICKI L Director Sell 10b5-1 22,000 $6.00 $132.1K 1,188,391 −1.8% of holding
Sell 10b5-1 61,493 $6.44 $396.0K 13,920,778 −0.4% of holding
Sell 10b5-1 127,938 $6.39 $817.7K 13,982,271 −0.9% of holding
Sell 10b5-1 235,971 $6.38 $1.5M 14,110,209 −1.6% of holding
Sell 10b5-1 227,803 $6.15 $1.4M 14,346,180 −1.6% of holding
O'Byrne Jason EVP & Chief Financial Officer Sell 6,799 $5.56 $37.8K 110,701 −5.8% of holding
de Verneuil Vanina EVP, General Counsel, Corp Sec Sell 10b5-1 2,385 $5.16 $12.3K 78,210 −3% of holding
SATO VICKI L Director Sell 10b5-1 22,000 $5.64 $124.0K 1,210,391 −1.8% of holding
de Verneuil Vanina EVP and General Counsel Sell 1,365 $5.86 $8.0K 80,595 −1.7% of holding
Sell 10b5-1 100 $6.49 $649 14,573,983 −0% of holding
Sell 10b5-1 24,453 $6.50 $159.0K 14,574,083 −0.2% of holding
Sell 10b5-1 66,403 $6.05 $401.6K 14,598,536 −0.5% of holding
Sell 10b5-1 46,696 $5.96 $278.3K 14,664,939 −0.3% of holding
Sell 10b5-1 154,383 $5.99 $924.7K 14,711,635 −1% of holding
Sell 10b5-1 144,266 $6.15 $887.7K 14,866,018 −1% of holding
Sell 10b5-1 109,675 $6.30 $691.0K 15,010,284 −0.7% of holding
Sell 10b5-1 220,535 $6.20 $1.4M 15,119,959 −1.4% of holding
Sell 10b5-1 12,844 $6.10 $78.4K 15,340,494 −0.1% of holding
Sell 10b5-1 16,671 $6.07 $101.2K 15,353,338 −0.1% of holding
Sell 10b5-1 2,300 $6.08 $14.0K 15,370,009 −0% of holding
Sell 10b5-1 249,060 $6.14 $1.5M 15,372,309 −1.6% of holding
Sell 10b5-1 466,242 $6.05 $2.8M 15,621,369 −2.9% of holding
Sell 10b5-1 72,133 $5.60 $404.2K 16,087,611 −0.4% of holding
Sell 10b5-1 73,955 $5.69 $420.6K 16,159,744 −0.5% of holding
Sell 10b5-1 450,342 $5.56 $2.5M 16,233,699 −2.7% of holding
SATO VICKI L Director Sell 10b5-1 22,000 $5.84 $128.4K 1,232,391 −1.8% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.